Community-acquired S. aureus infection in childhood: a multi-center study

Turk J Pediatr. 2023;65(3):469-478. doi: 10.24953/turkjped.2021.4583.

Abstract

Background: The prevalence of community-acquired methicillin-resistant S. aureus (CA-MRSA) has been increasing worldwide. We aimed to investigate the prevalence of MRSA in community-acquired S. aureus infections, the risk factors for CA-MRSA infection and the clinical features of CA-MRSA.

Methods: A multi-center study with prospective and retrospective sections was conducted. Patients ≥ 3 months old and ≤18 years of age who were diagnosed with community-acquired S. aureus infections were included in this study and the patients` information were reviewed from the medical and microbiological database of the hospital. A standard question form about living conditions and exposure risk factors was administered to the parents of patients. The CA-MRSA infections were compared with the methicillin-susceptible S. aureus (CAMSSA) infections in terms of the queried risk factors and clinical variables.

Results: We identified 334 pediatric patients with S. aureus infection, 58 (17.4%) had an infection with CAMRSA. The refugee rate was higher in the CA-MRSA group. There was no significant difference regarding the exposure risk. The treatment modalities and outcomes were similar.

Conclusions: The study was not able to show reliable clinical variables or epidemiological risk factors except for being a refugee for CA-MRSA infections. Empirical antibiotic treatment should therefore be determined according to the local CA-MRSA prevalence in patients presenting with a possible staphylococcus infection.

Keywords: bacteremia; cellulitis; immigrant; refugee; sulbactam ampicillin.

Publication types

  • Multicenter Study

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Child
  • Community-Acquired Infections* / microbiology
  • Humans
  • Infant
  • Methicillin / therapeutic use
  • Methicillin-Resistant Staphylococcus aureus*
  • Prospective Studies
  • Retrospective Studies
  • Staphylococcal Infections* / drug therapy
  • Staphylococcus aureus

Substances

  • Methicillin
  • Anti-Bacterial Agents